These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18041124)

  • 21. Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit.
    Sahu MK; Siddharth B; Choudhury A; Vishnubhatla S; Singh SP; Menon R; Kapoor PM; Talwar S; Choudhary S; Airan B
    Ann Card Anaesth; 2016; 19(2):281-7. PubMed ID: 27052070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of carbapenem testing: the COMPACT study.
    Nordmann P; Picazo JJ; Mutters R; Korten V; Quintana A; Laeuffer JM; Seak JC; Flamm RK; Morrissey I;
    J Antimicrob Chemother; 2011 May; 66(5):1070-8. PubMed ID: 21393160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nonfermentative gram-negative bacteria: isolation rates and antibiotic sensitivity].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM; Oreshkina TD
    Anesteziol Reanimatol; 2010; (3):12-8. PubMed ID: 20734840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005).
    Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):207-15. PubMed ID: 16949243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates.
    Turner PJ
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):217-22. PubMed ID: 19070453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015].
    Hao D; Hu Z; Liu X; Sun T; Wang T; Tian H; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):439-44. PubMed ID: 29920041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
    Kitzis MD; Acar JF; Gutmann L
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of bacterial isolates from Turkey--a report from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program.
    Eraksoy H; Basustaoglu A; Korten V; Kurt H; Ozturk R; Ulusoy S; Yaman A; Yuce A; Zarakolu P;
    J Chemother; 2007 Dec; 19(6):650-7. PubMed ID: 18230545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Lee H; Ko KS; Song JH; Peck KR
    Microb Drug Resist; 2011 Mar; 17(1):37-45. PubMed ID: 20950191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Susceptibility of clinical strains of gram-negative rods to selected beta-lactam antibiotics].
    Rokosz A; Sawicka-Grzelak A
    Med Dosw Mikrobiol; 1997; 49(3-4):191-8. PubMed ID: 9554152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China].
    Wang Q; Wang H; Yu Y; Xu X; Sun Z; Lu J; Yang B; Zhang L; Hu Z; Feng X; Xu Y; Ni Y; Mei Y; Liao K; Ji P; Chu Y
    Zhonghua Nei Ke Za Zhi; 2015 Oct; 54(10):837-45. PubMed ID: 26675021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections.
    Yaman A; Tasova Y; Kibar F; Inal AS; Saltoglu N; Buyukcelik O; Kurtaran B; Dundar IH
    Saudi Med J; 2004 Oct; 25(10):1403-9. PubMed ID: 15494811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
    Korten V; Ulusoy S; Zarakolu P; Mete B;
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Gram-negative bacteria in Brazilian hospitals: the MYSTIC Program Brazil 2003.
    Kiffer C; Hsiung A; Oplustil C; Sampaio J; Sakagami E; Turner P; Mendes C;
    Braz J Infect Dis; 2005 Jun; 9(3):216-24. PubMed ID: 16224628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian study.
    Gales AC; Azevedo HD; Cereda RF; Girardello R; Xavier DE;
    Braz J Infect Dis; 2011; 15(6):513-20. PubMed ID: 22218508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
    Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
    Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and resistance patterns of Pseudomonas aeruginosa in a tertiary care hospital in Kosovo.
    Lila G; Mulliqi-Osmani G; Bajrami R; Kurti A; Azizi E; Raka L
    Infez Med; 2017 Mar; 25(1):21-26. PubMed ID: 28353451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.